Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?

Dario Giugliano, Antonio Ceriello, Luca De Nicola, Pasquale Perrone-Filardi, Francesco Cosentino, Katherine Esposito

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?'. Together they form a unique fingerprint.

Medicine & Life Sciences